Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: A preliminary study

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 1094-1098

  Nakabayashi, Iwao ^a,b   Nakamura, Motonobu ^a,b   Kawakami, Koji ^c   Ohta, Toshihisa ^c   Kato, Ikuo ^c   Uchida, Kazumi ^c   Yoshida, Masaharu ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Tojinkai Medical Corporation   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

constipation; haemodialysis; p cresol; p cresyl sulphate; synbiotic

Indexed keywords

GALACTOSE OLIGOSACCHARIDE; OLIGOMATE 55N; PARA CRESOL; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; YAKULT BL SEICHOYAKU;

ABNORMAL FECES; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; BLOOD LEVEL; CLINICAL ARTICLE; DEFECATION; DEFECATION DISORDER; DEFECATION HABIT; FECES ANALYSIS; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HARD FECES; HEMODIALYSIS; HUMAN; LACTOBACILLUS CASEI; LOWER ABDOMINAL PAIN; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT DURATION; UPPER ABDOMINAL PAIN;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CRESOLS; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; SYNBIOTICS;

EID: 79952176810     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq624     Document Type: Article

References (24)

1. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-1943 (Pubitemid 36513344)
2. Jourde-Chiche N, Dou L, Cerini C et al. Protein-bound toxins-update 2009. Semin Dial 2009;22:334-339
3. de Loor H, Bammens B, Evenepoel P et al. Gas chromatographicmass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem 2005;51:1535-1538 (Pubitemid 41060897)
4. De Smet R, Van Kaer J, Van Vlem B et al. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003;49:470-478 (Pubitemid 36250208)
5. Meijers BK, Bammens B, De Moor B et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008;73:1174-1180 (Pubitemid 351620433)
6. Bammens B, Evenepoel P, Keuleers H et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006;69:1081-1087 (Pubitemid 43372184)
7. Schepers E, Meert N, Glorieux G et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 2007;22:592-596 (Pubitemid 46189906)
8. Meijers BK, Van Kerckhoven S, Verbeke K et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009;54:891-901
9. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 1996;81:288-302
10. Wu MJ, Chang CS, Cheng CH et al. Colonic transit time in long-term dialysis patients. Am J Kidney Dis 2004;44:322-327
11. Hida M, Aiba Y, Sawamura S et al. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996;74:349-355 (Pubitemid 26326708)
12. Hammer J, Oesterreicher C, Hammer K et al. Chronic gastrointestinal symptoms in hemodialysis patients. Wien Klin Wochenschr 1998;110:287-291 (Pubitemid 28211122)
13. Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br J Nutr 2002;88: S39-S49 (Pubitemid 35251942)
14. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008;111:1-66
15. Nomoto K. Prevention of postoperative microbial infection by synbiotics. Indian J Exp Biol 2008;46:557-561
16. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991;32:73-79
17. Niwa T. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection. Clin Chem 1993;39:108-111 (Pubitemid 23034966)
18. Yoshikawa M, Taguchi Y, Arashidani K et al. Determination of cresols in urine by high-performance liquid chromatography. J Chromatogr 1986;362:425-429 (Pubitemid 16048750)
19. de Loor H, Meijers BK, Meyer TW et al. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. J Chromatogr A 2009;1216:4684-4688
20. Niwa T, Yazawa T, Ise M et al. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron 1991;57:84-88
21. De Preter V, Vanhoutte T, Huys G et al. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 2007;292: G358-G368 (Pubitemid 46090279)
22. Ito M, Kimura M, Deguchi Y et al. Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism. J Nutr Sci Vitaminol 1993;39:279-288
23. Deguchi Y, Matsumoto K, Ito A et al. Effects of β1-4 galactooligosaccharides administration on defecation of healthy volunteers with constipation tendency. Jpn J Nutr 1997;55:13-22 (in Japanese)
24. Vinik AI, Freeman R, Erbas T. Diabetic autonomic neuropathy. Semin Neurol 2003;23:365-372 (Pubitemid 38437507)